Sort   by:  
 Page size 
TranscriptomicsLiver tumor/normal pairs
A major challenge to the study of tumor DNA copy number (CN) in clinical specimens is the lack of appropriate fresh frozen samples and thus a dependence on Formalin-Fixed Paraffin Embedded (FFPE) banked samples, which typically have more extensive clinical follow up information. However, on most hi...
ORGANISM(S): Homo sapiens 
2009-01-22 | E-GEOD-14353 | biostudies-arrayexpress
TranscriptomicsGender-specific gene expression in post-mortem human brain
Gender differences in brain development and in the prevalence of neuropsychiatric disorders such as depression have been reported. Gender differences in human brain might be related to patterns of gene expression. Microarray technology is one useful method for investigation of gene expression in bra...
ORGANISM(S): Homo sapiens 
2005-01-28 | GSE2164 | GEO
TranscriptomicsTranscription profiling of post-mortem human brain to investigate gender specific gene expression
Gender differences in brain development and in the prevalence of neuropsychiatric disorders such as depression have been reported. Gender differences in human brain might be related to patterns of gene expression. Microarray technology is one useful method for investigation of gene expression in bra...
ORGANISM(S): Homo sapiens 
2008-06-12 | E-GEOD-2164 | biostudies-arrayexpress
UnknownCollege Campus Food Pantry Program Evaluation: What Barriers Do Students Face to Access On-Campus Food Pantries?
Not available
S-EPMC9324299 | biostudies-literature
ProteomicsDetermination of protein expression changes due to treatment with chromatin remodeling inhibitor FHD-286 in patient-derived mutant NPM1 and FLT-ITD-expressing AML cells
We treated patient-derived mutant NPM1-and FLT3-ITD expressing AML cells with a chromatin remodeling inhibitor, FHD-286, at a dose of 100 nM, for 48 hours to determine FHD-286-mediated changes to the AML proteome.
ORGANISM(S): Homo sapiens (Human) 
2025-05-06 | PXD047967 | Pride
Chromatin remodelers Mutant npm1 Aml Fhd-286 
ProteomicsDetermination of protein expression changes due to treatment with chromatin remodeling inhibitor FHD-286 in MLL1-rearranged AML cells
We treated MLL1-rearranged AML MOLM13 cells with a chromatin remodeling inhibitor, FHD-286, at a dose of 100 nM, for different time intervals (up to 48 hours) to measure the time-dependent changes to the AML proteome
ORGANISM(S): Homo sapiens (Human) 
2025-05-26 | PXD047965 | Pride
Mll1-rearranged aml Chromatin remodelers Fhd-286 
UnknownPredicting Regression of Barrett's Esophagus-Can All the King's Men Put It Together Again?
Not available
S-EPMC11430295 | biostudies-literature
UnknownDifferential distribution and expression of Panton-Valentine leucocidin among community-acquired methicillin-resistant Staphylococcus aureus strains.
Not available
S-EPMC1169154 | biostudies-literature
TranscriptomicsFFPE study using MIP copy number platform - breast cancer I
A major challenge to the study of tumor DNA copy number (CN) in clinical specimens is the lack of appropriate fresh frozen samples and thus a dependence on Formalin-Fixed Paraffin Embedded (FFPE) banked samples, which typically have more extensive clinical follow up information. However, on most hig...
ORGANISM(S): Homo sapiens 
2010-05-05 | E-GEOD-14743 | biostudies-arrayexpress
Unknown14. Effects of an Opt-Out Protocol for Antibiotic De-escalation among Selected Patients with Suspected Sepsis: The DETOURS Trial
Not available
S-EPMC8643792 | biostudies-literature
Sort   by:  
 Page size